BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Janota B, Szczepańska E, Adamek B, Janczewska E. Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship? World J Hepatol 2023; 15(5): 641-648 [PMID: PMC10251274 DOI: 10.4254/wjh.v15.i5.641]
URL: https://www.wjgnet.com/1007-9327/full/v15/i5/641.htm
Number Citing Articles
1
Barbara Janota, Elżbieta Szczepańska, Kinga Noras, Ewa Janczewska. Lifestyle and Quality of Life of Women with Diagnosed Hypothyroidism in the Context of Metabolic DisordersMetabolites 2023; 13(10): 1033 doi: 10.3390/metabo13101033
2
Rohit A. Sinha, Eveline Bruinstroop, Paul M. Yen. Actions of thyroid hormones and thyromimetics on the liverNature Reviews Gastroenterology & Hepatology 2025; 22(1): 9 doi: 10.1038/s41575-024-00991-4
3
Wenting Zhou, Rui He, Ruwei Ou. Genetic insights and therapeutic avenues: unraveling the role of polyunsaturated fatty acids as mediators between hypothyroidism and Von Willebrand disease through Mendelian randomizationFrontiers in Genetics 2025; 15 doi: 10.3389/fgene.2024.1426401
4
Kamila Kasprzak-Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk. Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?International Journal of Molecular Sciences 2024; 25(7): 3746 doi: 10.3390/ijms25073746
5
Barbara Janota, Brygida Adamek, Elżbieta Szczepańska, Krzysztof Biernacki, Ewa Janczewska. Lifestyle and Quality of Life of Women Diagnosed with Hypothyroidism in the Context of Non-Alcoholic Fatty LiverMetabolites 2023; 13(12): 1174 doi: 10.3390/metabo13121174